1-4 of 4
Firoozeh Sahebi, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Relapse Risk Score to Predict Acute Myeloid Leukemia Relapse After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Based on Pre-Transplant Variables.

Boglarka Gyurkocza, M.D., Rainer Storb, M.D., Barry E. Storer, Ph., D., Thomas Chauncey, MD, Thoralf Lange, M.D., Ginna G. Laport, MD, Amelia Langston, M.D., Michael A. Pulsipher, M.D., Christopher Bredeson, M.D., Richard Maziarz, M.D., Benedetto Bruno, M.D., Finn Petersen, M.D., Michael Maris, M.D., Edward Agura, M.D., Andrew M. Yeager, M.D., Wolfgang A. Bethge, M.D., Firoozeh Sahebi, M.D., Frederick R. Appelbaum, M.D., David G. Maloney, M.D., Elihu H. Estey, M.D., Brenda M. Sandmaier, MD
Journal: Blood
Blood (2010) 116 (21): 3450.
https://doi.org/10.1182/blood.V116.21.3450.3450
Published: 2010
Journal Articles

Analysis of Risk Factors and Outcome for Extramedullary Relapses Post Allogeneic Stem Cell Transplantation for Myeloma.

Myo Htut, MD, Firoozeh Sahebi, M.D., George Somlo, MD, Pablo Parker, M.D., Chatchada Karanes, MD, Andy Dagis, Susan Hmwe, Tanya Paris, Joyce Murata-Collins, PhD, Leslie Popplewell, M.D., Joycelynne Palmer, PhD., Stephen Forman, M.D., Amrita Krishnan, M.D.
Journal: Blood
Blood (2010) 116 (21): 4562.
https://doi.org/10.1182/blood.V116.21.4562.4562
Published: 2010
Journal Articles

High Rate of Complete Remission (CR) and Upgraded Response with Weekly Maintenance Bortezomib Post Single Autologous Peripheral Stem Cell Transplant (PSCT) In Patients with Multiple Myeloma. Results of a Phase II Prospective Study

Firoozeh Sahebi, M.D., Amrita Krishnan, M.D., Leonardo Farol, MD, Ji-Lian Cai, MD, George Somlo, MD, Leslie Popplewell, M.D., R. Spielberger, M.D., Neil Martin Kogut, MD, Chatchada Karanes, MD, Christopher Ruel, Paul Frankel, Eunicia Reburiano, Margret O'Donnell, MD, Stephen Forman
Journal: Blood
Blood (2010) 116 (21): 2399.
https://doi.org/10.1182/blood.V116.21.2399.2399
Published: 2010
Journal Articles

Impacts of Cytogenetic Abnormalities and Prior Alemtuzumab on Outcomes of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)

Mohamed L. Sorror, MD, MSc, Barry Storer, PhD, Brenda M. Sandmaier, MD, Leanthe Braunert, MD, Ginna G. Laport, MD, Thomas Chauncey, MD, Christopher Bredeson, Richard T Maziarz, MD, Michael A. Pulsipher, MD, Edward Agura, MD, Michael T. Maris, MD, Lars Vindelov, MD, Firoozeh Sahebi, M.D., Peter McSweeney, Benedetto Bruno, MD, Amelia Langston, MD, Rainer F. Storb, MD, David G. Maloney
Journal: Blood
Blood (2010) 116 (21): 2364.
https://doi.org/10.1182/blood.V116.21.2364.2364
Published: 2010